Novo Nordisk to cut US list prices of Ozempic, Wegovy as of 2027 - Reuters
Novo Nordisk to cut US list prices of Ozempic, Wegovy as of 2027 Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPU0dHTmFzZEszcjUwQWVrRG1NdTg2Y09RTnlQank3NVR1LUEtVzM2M2NRTi1haGxHdFlFN2lBYnF6OWNYQUV6cFAySVpFcWoyc2wtNnVQcDNQT2Z4dEZFek12M21SVTBXWWNCTjNCUEt2bGFnYm9OMWhOZ3kwR3YxY3Y5WmdWbWFxNUtGSFFmUjBhS2syQVpiZGFqQVdvcmlFeTNyUlIxLUVfLXJCcU9KZjlPY3Bxck40TzgzMktvcmM?oc=5" target="_blank">Novo Nordisk to cut US list prices of Ozempic, Wegovy as of 2027</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
China's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMUnited CEO expects gradual fare increases in 2027 as demand stays strong - Reuters
United CEO expects gradual fare increases in 2027 as demand stays strong Reuters
August 25, 2026 at 03:33 PMNorway to give over $9 billion to Ukraine in 2027 - Reuters
Norway to give over $9 billion to Ukraine in 2027 Reuters
August 23, 2026 at 09:32 AMUS employer healthcare costs set to rise 9.5% in 2027, Aon says - Reuters
US employer healthcare costs set to rise 9.5% in 2027, Aon says Reuters
August 20, 2026 at 03:54 PMCelon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump Reuters
August 20, 2026 at 02:09 PM